BioLargo Inc.
BioLargo Inc. is a billboard sponsor of Streetwise Reports and paid a fee for this company profile page. Please refer to the important disclosures below for additional details.
Recent Articles:
Cleantech Co. Increases Revenue, Cash Flow in Q2/24
Pet Odor Product Continues to Be Lucrative for Clean Tech Co.
Clean Tech Co. Continues to See Rising Revenues
'Everyone's Drinking It': More 'Forever Chemicals' Showing Up Worldwide
AI Data Centers, EVs to Lead New Surge in Energy Demand
Expert Says Cleantech Stock's Chart Look Better Than Ever
More Articles
Expert Comments:
| "BioLargo Inc. announced Q2/24 revenues that again showed strong year-over-year and modest quarter-over-quarter growth. Revenues were $5M, up from $1.4M a year ago and up 5% sequentially as Pooph sales saw continued good performance." | |
|
|
|
| "BioLargo Inc. announced Q1/24 revenues that again showed strong year-over-year and quarter-over-quarter growth. The company generated positive cash flow from operations and increased its shareholders' equity to $5.1M, all while maintaining minimal debt and ending the quarter with $4.3M in cash." | |
|
|
|
| "The final PFAS regulations from the Environmental Protection Agency validate BioLargo Inc.'s water treatment vision. . .under the new rule, water utilities must monitor PFAS chemicals and would be required to notify the public and reduce contamination if levels exceeded the new standard. . .the large emerging market for PFAS removal and the company's growing validation in this opportunity should not be overlooked." | |
|
|
|
| "BioLargo Inc. announced that 2023 revenues more than doubled the level the company reported in 2022, making it the second year in a row that revenues have grown at that rate. BioLargo maintained gross margin at 50%, doubled shareholders' equity, all while maintaining minimal debt and ending the year with $3.5M in cash." | |
|
|
|
| "The fundamentals of BioLargo Inc. are superb with everything coming together in a positive manner after many years of work. So ultimately, the company's stock is believed headed much higher." | |
|
|
|
| "BioLargo Inc. announced that its 2023 revenues more than doubled the level it reported in 2022, making it the second year in a row that revenues have grown at that rate. . .the company's results continue to be driven by Pooph sales, its pet odor control product line that is being sold through national retailers like Amazon, Walmart, Chewy and a growing list of other retailers." | |
|
|
More Expert Comments
Experts Following This Company
| Clive Maund – CliveMaund.com | |
| Richard Ryan – Oak Ridge Financial | |
 |
Chris Temple, Editor and Publisher – The National Investor |
Company News
8/13/2024 – BioLargo Earnings Results Webcast and Conference Call on Wednesday, August 14, 2024 - 1:30 PM Pacific Time
8/6/2024 – BioLargo Achieves Record Quarterly Revenue of $5 Million for Second Quarter of 2024
6/20/2024 – BioLargo Engineering Increases Ongoing Revenue with Another Air Force Contract
6/12/2024 – BioLargo Subsidiary Clyra Medical Selects Keystone Industries to Support Manufacturing of its Medical Products
6/11/2024 – BioLargo Manufactures First Cellinity Battery Cells, a Safer Alternative to Lithium-ion
6/7/2024 – BioLargo Engineering Secures Multi-Year Air Force Base Air Compliance Project
5/13/2024 – OTC Markets Group Welcomes BioLargo, Inc. to OTCQX
Important Disclosures
BioLargo Inc. is a Billboard advertiser of Streetwise Reports and pays a flat fee. Fees fund both sponsor-specific activities and general report activities. Sponsor-specific activities may include aggregating content and publishing that content on the Streetwise Reports site, creating and maintaining company landing pages, interviewing key management, posting a banner/billboard, and/or issuing press releases.
The fees also cover the costs for Streetwise Reports to publish and syndicate investment opinion and comments, and also to curate or create sector-specific content.
Billboard advertising monthly fees range from $3,000 to $5,000.
This landing page contains a summary of the company that was prepared by that company.
Some landing pages contain investing highlights and a catalyst calendar that are prepared by that company.
The Expert Comments and Experts Following This Company sections of the landing page are compiled by Streetwise Reports.
There may be other information about the company that is not placed on the landing page, and Streetwise Reports does not guarantee the accuracy or thoroughness of the information contained on the landing page.
Readers should conduct their own research for all information publicly available concerning the company.
This landing page may be considered advertising for the purposes of 18 U.S.C. 1734.
Streetwise Company Fact Sheet2024/8/31 20:50:45
(BLGO:OTCQX)
Analyst coverage
| Oak Ridge Financial — Richard Ryan |
Newsletter coverage
| — |
| — |
Company News
| View Latest News |
Streetwise Reports Articles
| 08/23/2024 - View Article |
| 08/19/2024 - View Article |
| 08/07/2024 - View Article |
| 07/17/2024 - View Article |
| 07/09/2024 - View Article |
Streetwise - BioLargo Inc. Ownership Overview*
BioLargo Inc. (BLGO:OTCQB)
| Invest-prove-partner business model that leverages credible partners to maximize impact | |
| Unrivaled technologies to solve challenges in emerging environmental markets | |
| Heading toward profitability, with average QoQ revenue growth of +25% over past two years |
© 2024 Streetwise Reports. All rights reserved.
Streetwise Reports is registered with the U.S. Patent and Trademark Office.
